117 Grants (Page 1 of 5)
2023
Development of a mouse model to test HPV Antiviral compounds
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI174247-01), $198,125USD, 2022-11-07 -- 2024-10-31
2022
Small Molecule E6 Inhibitors to Treat Dysplasia Caused by HPV Infections
ANDROPHY, ELLIOT J and Lu, Zhijian
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R43AI167573-01), $298,527USD, 2022-07-01 -- 2023-06-30
 
Small Molecule E6 Inhibitors to Treat Oropharyngeal Cancers Caused by HPV Infections
ANDROPHY, ELLIOT J and Lu, Zhijian
National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) (ID: 1R43DE031495-01A1), $275,766USD, 2022-09-01 -- 2023-08-31
2021
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
ANDROPHY, ELLIOT J and Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA252715-01A1), $632,904USD, 2021-05-01 -- 2026-04-30
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS082284-08), $384,780USD, 2013-08-15 -- 2024-04-30
2020
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS082284-07), $386,415USD, 2013-08-15 -- 2024-04-30
2019
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-24), $359,385USD, 09/24/1993 -- 06/30/2020
 
Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA
ANDROPHY, ELLIOT J⋅HODGETTS, KEVIN and Lorson, Christian L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R33NS095139-03), $212,328USD, 02/01/2018 -- 01/31/2020
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 2R01NS082284-06A1), $386,779USD, 08/15/2013 -- 04/30/2024
2018
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-23), $370,500USD, 1993-09-24 -- 2020-06-30
 
Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA
ANDROPHY, ELLIOT J⋅HODGETTS, KEVIN and Lorson, Christian L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 4R33NS095139-02), $505,768USD, 02/01/2018 -- 01/31/2020
2017
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-22), $370,500USD, 09/24/1993 -- 06/30/2020
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS082284-05), $341,250USD, 08/15/2013 -- 05/31/2019
 
The Indiana Cutaneous Biological Research Training Program
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5T32AR062495-05), $117,250USD, 04/01/2013 -- 03/31/2019
2016
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-21), $370,500USD, 09/24/1993 -- 06/30/2020
 
Optimization of a novel series of thiazolopyridines for the treatment of SMA
ANDROPHY, ELLIOT J⋅HODGETTS, KEVIN and Lorson, Christian L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R21NS088522-02), $420,850USD, 04/01/2015 -- 03/31/2017
 
Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA
ANDROPHY, ELLIOT J⋅HODGETTS, KEVIN and Lorson, Christian L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS095139-01), $431,954USD, 01/01/2016 -- 12/31/2017
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 3R01NS082284-04S1), $55,689USD, 08/15/2013 -- 05/31/2018
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 4R01NS082284-04), $341,250USD, 08/15/2013 -- 05/31/2018
 
The Indiana Cutaneous Biological Research Training Program
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 4T32AR062495-04), $147,408USD, 04/01/2013 -- 03/31/2018
2015
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA058376-20A1), $370,500USD, 09/24/1993 -- 06/30/2020
 
Optimization of a novel series of thiazolopyridines for the treatment of SMA
ANDROPHY, ELLIOT J⋅HODGETTS, KEVIN and Lorson, Christian L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS088522-01A1), $447,563USD, 04/01/2015 -- 03/31/2017
 
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS082284-03), $340,848USD, 08/15/2013 -- 05/31/2016
 
The Indiana Cutaneous Biological Research Training Program
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5T32AR062495-03), $114,489USD, 04/01/2013 -- 03/31/2016
 
Toward drug treatment of spinal muscular atrophy: Mechanism of action
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R21NS087379-02), $195,000USD, 08/15/2014 -- 07/31/2017